| The Influence of Early Measurements Onto the Estimated Kidney Dose in [177Lu][DOTA0,Tyr3]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine … A Delker, H Ilhan, C Zach, J Brosch, FJ Gildehaus, S Lehner, ... Molecular imaging and biology 17, 726-734, 2015 | 43 | 2015 |
| Feasibility of single-time-point dosimetry for radiopharmaceutical therapies X Hou, J Brosch, C Uribe, A Desy, G Böning, JM Beauregard, A Celler, ... Journal of Nuclear Medicine 62 (7), 1006-1011, 2021 | 37 | 2021 |
| Toward high-throughput artificial intelligence-based segmentation in oncological PET imaging F Yousefirizi, AK Jha, J Brosch-Lenz, B Saboury, A Rahmim PET clinics 16 (4), 577-596, 2021 | 31 | 2021 |
| Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid … A Gosewisch, A Delker, S Tattenberg, H Ilhan, A Todica, J Brosch, ... EJNMMI research 8, 1-16, 2018 | 31 | 2018 |
| 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT A Gosewisch, H Ilhan, S Tattenberg, A Mairani, K Parodi, J Brosch, ... EJNMMI research 9, 1-14, 2019 | 28 | 2019 |
| Voxel-wise analysis of dynamic 18F-FET PET: a novel approach for non-invasive glioma characterisation L Vomacka, M Unterrainer, A Holzgreve, E Mille, A Gosewisch, J Brosch, ... EJNMMI research 8, 1-13, 2018 | 28 | 2018 |
| Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT A Gosewisch, M Schleske, FJ Gildehaus, I Berg, L Kaiser, J Brosch, ... European journal of nuclear medicine and molecular imaging 48, 1260-1261, 2021 | 26 | 2021 |
| 3D image-based dosimetry for Yttrium-90 radioembolization of hepatocellular carcinoma: Impact of imaging method on absorbed dose estimates J Brosch, A Gosewisch, L Kaiser, M Seidensticker, J Ricke, J Zellmer, ... Physica Medica 80, 317-326, 2020 | 21 | 2020 |
| Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T J Brosch-Lenz, C Uribe, A Gosewisch, L Kaiser, A Todica, H Ilhan, ... EJNMMI physics 8, 1-17, 2021 | 20 | 2021 |
| Toward single-time-point image-based dosimetry of 177Lu-PSMA-617 therapy J Brosch-Lenz, A Delker, F Völter, LM Unterrainer, L Kaiser, P Bartenstein, ... Journal of Nuclear Medicine 64 (5), 767-774, 2023 | 18 | 2023 |
| Differential spatial distribution of TSPO or amino acid PET signal and MRI contrast enhancement in gliomas L Kaiser, A Holzgreve, S Quach, M Ingrisch, M Unterrainer, FJ Dekorsy, ... Cancers 14 (1), 53, 2021 | 16 | 2021 |
| Role of artificial intelligence in theranostics: toward routine personalized radiopharmaceutical therapies J Brosch-Lenz, F Yousefirizi, K Zukotynski, JM Beauregard, V Gaudet, ... PET clinics 16 (4), 627-641, 2021 | 16 | 2021 |
| Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology A Rahmim, J Brosch-Lenz, A Fele-Paranj, F Yousefirizi, M Soltani, C Uribe, ... Frontiers in oncology 12, 1062592, 2022 | 11 | 2022 |
| Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy F Völter, L Mittlmeier, A Gosewisch, J Brosch-Lenz, FJ Gildehaus, ... Diagnostics 11 (3), 428, 2021 | 11 | 2021 |
| Annual Congress of the European Association of Nuclear Medicine October 12–16, 2019 Barcelona, Spain LGM Kaiser, SA Ahmadi, M Unterrainer, A Holzgreve, E Mille, ... Eur J Nucl Med Mol Imaging 46, 1-952, 2019 | 7 | 2019 |
| Long-term nephrotoxicity of 177Lu-PSMA radioligand therapy L Steinhelfer, L Lunger, L Cala, CH Pfob, C Lapa, PE Hartrampf, AK Buck, ... Journal of Nuclear Medicine 65 (1), 79-84, 2024 | 6 | 2024 |
| Feasibility of radiomic feature harmonization for pooling of [18F] FET or [18F] GE-180 PET images of gliomas AJ Zounek, NL Albert, A Holzgreve, M Unterrainer, J Brosch-Lenz, ... Zeitschrift für Medizinische Physik 33 (1), 91-102, 2023 | 6 | 2023 |
| Theranostic Digital Twins: An indispensable prerequisite for personalized cancer care J Brosch-Lenz, C Uribe, A Rahmim, B Saboury Journal of Nuclear Medicine, 2022 | 5 | 2022 |
| Quantitative myocardial perfusion SPECT/CT for the assessment of myocardial tracer uptake in patients with three-vessel coronary artery disease: Initial experiences and results S Lehner, I Nowak, M Zacherl, J Brosch-Lenz, M Fischer, H Ilhan, ... Journal of Nuclear Cardiology 29 (5), 2511-2520, 2022 | 4 | 2022 |
| An international study of factors affecting variability of dosimetry calculations, part 2: overall variabilities in absorbed dose J Brosch-Lenz, S Ke, H Wang, E Frey, YK Dewaraja, J Sunderland, ... Journal of Nuclear Medicine 64 (7), 1109-1116, 2023 | 3 | 2023 |
